Surgical correction of ischaemic mitral regurgitation - still a long way to go by Kolh, Philippe
EDITORIAL
Surgical correction of ischaemic mitral
regurgitation—still a long way to go
Philippe Kolh*
Service de Cardiochirurgie, CHU Sart Tilman, B 35 Sart Tilman, Lie`ge 4000, Belgium
Online publish-ahead-of-print 12 December 2007
This editorial refers to ‘Five-year echocardiographic
results of combined undersized mitral ring annuloplasty
and coronary artery bypass grafting for chronic ischaemic
mitral regurgitation’ by S. Gelsomino et al., on page 231
Elegant experimental work has helped in understanding the
pathogenesis of chronic ischaemic mitral regurgitation (IMR),
which appears to be the consequence of a combination of two
distinct anatomical abnormalities.1 Globally, annular dilatation
occurs secondary to left ventricular (LV) enlargment, causing
incomplete coaptation of the mitral valve despite normal leaflet
motion. Locally, inferior wall remodelling produces papillary
muscle displacement with restricted motion of the mitral leaflets.
Chronic IMR, an independent predictor of mortality with a
reported survival of 40–60% at 5 years,2–5 is a progressive dis-
order in which MR-related LV volume overload promotes
further LV remodelling, leading to worsened MR. Therefore, surgi-
cal correction, either by replacement or repair, is recommended
for 3þ and 4þ IMR.6 Furthermore, repair, as compared with
replacement, appears to benefit most patients with IMR, with the
possible exceptions of very high hisk group, such as patients in
New York Heart Association (NYHA) functional class IV or
those requiring emergency surgery.3
Many divergent approaches to IMR repair have been used, such as
undersized flexible ring annuloplasty, selective valve replacement,
uniform chordal sparing valve replacement, transection of secondary
chordae, suture annuloplasty, posterior leaflet patch extension,
annular cinching, and papillary muscle sling.7 For the last decade,
however, most authors have pursued the consistent approach of
routine rigid ring annuloplasty and complete coronary artery revas-
cularization to treat IMR, with good short-term success.3 However,
long-term results are more difficult to obtain and analyse.
Gelsomino et al.8 report 5-year echocardiographic results of
combined undersized mitral ring annuloplasty and coronary
artery bypass grafting (CABG) in patients with chronic IMR.
Among 251 prospectively enrolled patients operated on in a
single institution over a 6-year period, 14 patients with significant
residual MR, either intraoperatively or at hospital discharge, were
excluded from the study. There were two early and 15 late
deaths. Serial echocardiograms were performed in 220 survivors
at baseline, discharge, and annually thereafter, with a median
follow-up of 32.9 months, while 61 patients reached 5-year
control. Five-year survival and 5-year freedom from reoperation
for failed repair were 83.2+4.4 and 78.2+4.9%, respectively.
LV volumes decreased and sphericity indexes improved at
discharge and at 1-year follow-up, while MR remained stable,
but these values worsened at 3- and 5-year follow-up, while MR
reincreased. LV reverse remodelling was observed in 44.2% of
patients, while 10% developed further LV dilatation. Predictive
echocardiographic factors of recurrent MR were end-systolic
volume, sphericity index, myocardial performance index, and
wall motion score index. Gelsomino et al.8 report important
results that should be placed in perspective with other recent
studies, in particular concerning patient population, ring mor-
phology and size, operative results, and long-term recurrence
of MR.
The cohort of patients studied by Gelsomino et al.8 is hom-
ogenous, with inclusion criteria defined as myocardial infarction
.16 days, coronary artery stenosis of at least 75%, corresponding
regional wall motion abnormality, and type IIIb leaflet dysfunction
according to Carpentier’s classification,9 with or without annular
dilatation. Patients with isolated type I (normal leaflet motion
with isolated annular dilatation) or type II (excessive leaflet
motion) mitral valve disease were excluded.
A Carpentier’s classic (rigid) ring was implanted in 133 patients,
and a physio (partly flexible in the posterior part) ring in 118
patients. It should be noted that recent studies have linked
flexible posterior bands with significant recurrent MR.5 Patients
with IMR can develop dilatation of the anterior annulus between
the trigones. Because posterior flexible bands do not correct
intertrigonal dilatation, they may not effectively ensure restoration
of an adequate leaflet coaptation surface. However, the ring
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used, classic or physio, was not predictive of recurrent MR in this
study.
A downsizing of two ring sizes was performed in all patients,
while no patient received a ring .30 mm. It is widely accepted
that use of an appropriately downsized ring is the current single
most important aspect of mitral valve repair for IMR. This is
important to overcorrect the septal-lateral dimension and ensure
adequate surface of coaptation between tethered leaflets. The
fear of systolic anterior motion following downsizing is unnecess-
ary because of the widened aorto-mitral angle in this type of
pathology.
Operative mortality for combined mitral valve surgery
and CABG, although historically high, is now in the range of 4–
7%.7,10 Gelsomino et al.8 report an operative mortality of 0.8%,
which is excellent. Therefore, an appropriate long-term follow-up
can be obtained and analysed. Furthermore, patients with MR at
discharge were excluded from the study. This should be empha-
sized, as freedom from reoperation, reverse ventricular remodel-
ling, and improvements in quality of life are at least partly
dependent on elimination of MR at surgery.
Certainly, significant degrees of residual MR (moderate or
severe) should most often trigger a second bypass run and appro-
priate corrective action, such as further ring downsizing, leaflet
patch extension, correction of unrecognized prolapse, or, possibly,
valve replacement. It should also be remembered that post-bypass
transoesophageal echocardiography underestimates MR because
of low aferload during anaesthesia. This need for a second
bypass run should probably not exceed 5% with experienced sur-
geons. Only in exceptional circumstances should patients leave the
operating room with significant residual MR, such as when a valve
is considered irreparable or non-replacable (i.e. massive calcifica-
tion) or when the risks of a second bypass run exceed the benefits.
Long-term results of repair for IMR are difficult to obtain, partly
because death is an important competing end-point in the evalu-
ation of repair failure. Freedom from operation often overesti-
mates the success of a procedure, because many patients with
recurrent MR will not undergo reoperation for several reasons,
such as good functional class, advanced age, poor left ventricular
ejection fraction (LVEF), co-morbidities, or the patient’s wishes.
Therefore, recurrence of MR is a much more precise indicator
of procedural success.
Whereas good results have been reported,11 high late recur-
rence rates of MR after ring annuloplasty have recently been pub-
lished.5,12,13 McGee et al.5 reported a 28% recurrence rate of 3þ
or 4þ MR at 6 months. Furthermore, Serri et al.13 reported a
recurrence rate of 36% for 2þ MR and 20% for 3þ to 4þ MR
at 28 months, while Tahta et al.12 reported a recurrence rate for
2þ to 4þ MR of 29% at 35 months.
In contrast, Bax et al.11 reported absent or minimal MR at 18
months, with a high proportion of patients experiencing reverse
remodelling, with a significant decrease in left ventricular and left
atrial diameters, and LVEF increase. Braun et al.14 identified pre-
operative LV end-diastolic dimensions as the single best factor in
predicting occurrence of reverse remodelling, with a cut-off
value of 65 mm, and concluded that reverse LV remodelling
occurs in the majority of patients, but is however limited by pre-
operative LV dimensions. Therefore, these authors14 encourage
the use of additional surgical procedures, such as the application
of a CorCap cardiac support device (Acorn Cardiovascular, Inc.,
St Paul, MN, USA) or LV restoration therapy when LV end-
diastolic diameter is .65 or .80 mm, respectively.
In the study of Gelsomino et al.,8 LV volumes decreased and
sphericity indexes improved at discharge and at 1-year follow-up,
while MR remained stable, but these values worsened at 3- and
5-year follow-up, while MR reincreased. Such results, with patients
experiencing late MR, as long as 5 years after the initial surgical
procedure, emphasize the importance of long-term follow-up
that should include appropriate imaging to evaluate the success
of valve repair for IMR, whichever the technique used.
Longitudinal studies including regular echocardiographic
follow-up should be the gold standard to define the true efficacy
of mitral valve repair techniques. Echocardiographic data are the
best surrogate for recurrent MR, as opposed to survival or reo-
peration rate. Novel surgical techniques, such as ventricular resyn-
chronization, infarct restraint, ventricular reconstruction, posterior
leaflet patch extension, annular cinching, or chordal transection,
can only be evaluated in the long term using imaging techniques.
The best hope to improve outcomes in those high-risk patients
may be to focus efforts on early intervention to prevent the detri-
mental myopathic changes consequent to ischaemic remodelling.
Survival after mitral valve surgery and CABG is most probably
determined primarily by the extent of coronary artery disease
and LV dysfunction. Therefore, the sequence of myocardial infarc-
tion and remodelling associated with IMR has a greater impact on
survival than the degree of MR. Reverse remodelling should be the
ultimate goal of the surgeon, as it decreases the stress on the valv-
ular and subvalvular apparatus and therefore consolidates the
result.
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Huge pseudoaneurysm of deep femoral artery without history of
catheterization
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A 60-year-old man with a history of stroke had a sudden pain and severe swelling in
the left femur (Panel A). Echocardiography of the femoral artery showed a huge pseu-
doaneurysm of the deep femoral artery. Colour flow imaging shows a huge pseudoa-
neurysm (Panel B) of the deep femoral artery and the internal flow (90  130 
120 mm). Three-dimensional contrast-enhanced computed tomography showed a
projection of the femur bone, but no stenosis of the abdominal and iliac artery
(Panel C). Operation was performed and revealed the perforation of the femoral
artery by the projection of the thighbone. Microscopically, this cartilaginous
tumour permeated trabecular bone. Photomicrograph of the projection of thighbone
showed mildly nuclear atypia of tumour cells and increased cellularity (Panel D),
suggesting chondrosarcoma (haematoxylin and eosin stain, original magnification
40). The patient was discharged from the hospital in a good condition.
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